Landos Biopharma, Inc. PE Ratio 2020-2024 | LABP

Current and historical p/e ratio for Landos Biopharma, Inc. (LABP) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Landos Biopharma, Inc. PE ratio as of May 27, 2024 is .

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-23 22.93 0.00
2024-03-31 21.48 $-3.99 0.00
2023-12-31 3.66 $-3.46 0.00
2023-09-30 3.88 $-3.77 0.00
2023-06-30 4.21 $-4.83 0.00
2023-03-31 0.30 $-7.00 0.00
2022-12-31 0.50 $-9.80 0.00
2022-09-30 0.65 $-13.70 0.00
2022-06-30 0.73 $-14.90 0.00
2022-03-31 1.48 $-10.90 0.00
2021-12-31 4.80 $-11.00 0.00